- Home
- QMMM vs TENX Comparison
QMMM vs TENX Comparison
Compare QMMM & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QMMM
- TENX
- Stock Information
- Founded
- QMMM 2005
- TENX 1967
- Country
- QMMM Hong Kong
- TENX United States
- Employees
- QMMM N/A
- TENX N/A
- Industry
- QMMM
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- QMMM
- TENX Health Care
- Exchange
- QMMM NYSE
- TENX Nasdaq
- Market Cap
- QMMM 19.6M
- TENX 21.6M
- IPO Year
- QMMM 2024
- TENX N/A
- Fundamental
- Price
- QMMM $1.26
- TENX $5.95
- Analyst Decision
- QMMM
- TENX Strong Buy
- Analyst Count
- QMMM 0
- TENX 3
- Target Price
- QMMM N/A
- TENX $16.00
- AVG Volume (30 Days)
- QMMM 2.8M
- TENX 44.3K
- Earning Date
- QMMM 08-21-2025
- TENX 08-12-2025
- Dividend Yield
- QMMM N/A
- TENX N/A
- EPS Growth
- QMMM N/A
- TENX N/A
- EPS
- QMMM N/A
- TENX N/A
- Revenue
- QMMM $2,698,229.00
- TENX N/A
- Revenue This Year
- QMMM N/A
- TENX N/A
- Revenue Next Year
- QMMM N/A
- TENX N/A
- P/E Ratio
- QMMM N/A
- TENX N/A
- Revenue Growth
- QMMM N/A
- TENX N/A
- 52 Week Low
- QMMM $0.54
- TENX $2.80
- 52 Week High
- QMMM $13.00
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- QMMM N/A
- TENX 51.83
- Support Level
- QMMM N/A
- TENX $5.62
- Resistance Level
- QMMM N/A
- TENX $6.35
- Average True Range (ATR)
- QMMM 0.00
- TENX 0.46
- MACD
- QMMM 0.00
- TENX 0.01
- Stochastic Oscillator
- QMMM 0.00
- TENX 41.49
About QMMM QMMM HOLDINGS LIMITED
QMMM Holdings Ltd is a digital advertising and marketing production services company. It operates through its two wholly owned subsidiaries: ManyMany Creations and Quantum Matrix. It has used interactive design, animation, art-tech and virtual technologies in over 500 commercial campaigns. The company has worked with large domestic and international banks, real estate developers, amusement parks, top international athletic apparel and footwear brands, and luxury cosmetic products and international brands for their advertising and creation work in Hong Kong. Its clients include local and international banks, real-estate developers, luxury brands, high fashion houses, and theme parks.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.